Vitronectin: Growth factor complexes hold potential as a wound therapy approach

Journal of Investigative Dermatology

Volumn 128, Issue 6, 2008, Pages 1535-1544

  Upton, Zee ^a   Cuttle, Leila ^b   Noble, Anthony ^a   Kempf, Margit ^b   Topping, Gemma ^a   Malda, Jos ^a   Xie, Yan ^a   Mill, Julie ^b   Harkin, Damien G ^a   Kravchuk, Olena ^b   Leavesley, David I ^a   Kimble, Roy M ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; INTEGRIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; VITRONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SWINE; WOUND; WOUND CARE; WOUND DRESSING; WOUND FLUID; WOUND HEALING;

EID: 43749097878     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701148     Document Type: Article

References (56)

1. S.L. Ainscough Z. Barnard Z. Upton D.G. Harkin Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation Exp Eye Res 83 2006 1505 1514
2. B.S. Atiyeh S.N. Hayek S.W. Gunn New technologies for burn wound closure and healing—review of the literature Burns 31 2005 944 956
3. M.L. Bayne J. Applebaum G.G. Chicchi R.E. Miller M.A. Cascieri The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor J Biol Chem 265 1990 15648 15652
4. R. Blakytny E.B. Jude J. Martin Gibson A.J. Boulton M.W. Ferguson Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers J Pathol 190 2000 589 594
5. D. Breitkreutz V.M. Schoop N. Mirancea M. Baur H.J. Stark N.E. Fusenig Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants Eur J Cell Biol 75 1998 273 286
6. G.L. Brown L.B. Nanney J. Griffen A.B. Cramer J.M. Yancey L.J. Curtsinger III Enhancement of wound healing by topical treatment with epidermal growth factor N Engl J Med 321 1989 76 79
7. B. Bucalo W.H. Eaglstein V. Falanga Inhibition of cell proliferation by chronic wound fluid Wound Repair Regen 1 1993 181 186
8. A. Burd C. Yuen A global study of hospitalized paediatric burn patients Burns 31 2005 432 438
9. K.H. Chakrabarty R.A. Dawson P. Harris C. Layton M. Babu L. Gould Development of autologous human dermal–epidermal composites based on sterilized human allodermis for clinical use Br J Dermatol 141 1999 811 823
10. M. Christofidou-Solomidou M. Bridges G.F. Murphy S.M. Albelda H.M. DeLisser Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras Am J Pathol 151 1997 975 983
11. L. Cuttle M. Kempf G.E. Phillips J. Mill M.T. Hayes J.F. Fraser A porcine deep dermal partial thickness burn model with hypertrophic scarring Burns 32 2006 806 820
12. R.A. Dawson Z. Upton J. Malda D.G. Harkin Preparation of cultured skin for transplantation using insulin-like growth factor I in conjunction with insulin-like growth factor binding protein 5, epidermal growth factor, and vitronectin Transplantation 81 2006 1668 1676
13. S.L. Drinkwater A. Smith K.G. Burnand What can wound fluids tell us about the venous ulcer microenvironment? Int J Low Extrem Wounds 1 2002 184 190
14. S.R. Edmondson S.P. Thumiger G.A. Werther C.J. Wraight Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems Endocr Rev 24 2003 737 764
15. X. Fu X. Li B. Cheng W. Chen Z. Sheng Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years Wound Repair Regen 13 2005 122 130
16. X. Fu Z. Shen Y. Chen J. Xie Z. Guo M. Zhang Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns Lancet 352 1998 1661 1664
17. R.D. Galiano O.M. Tepper C.R. Pelo K.A. Bhatt M. Callaghan N. Bastidas Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells Am J Pathol 164 2004 1935 1947
18. R.D. Galiano L.L. Zhao D.R. Clemmons S.I. Roth X. Lin T.A. Mustoe Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model J Clin Invest 98 1996 2462 2468
19. F.G. Giancotti E. Ruoslahti Integrin signaling Science 285 1999 1028 1032
20. R. Gillitzer M. Goebeler Chemokines in cutaneous wound healing J Leukoc Biol 69 2001 513 521
21. R. Goldman Growth factors and chronic wound healing: past, present, and future Adv Skin Wound Care 17 2004 24 35
22. G.A. Hamon T.K. Hunt E.M. Spencer In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds Growth Regul 3 1993 53 56
23. N. Harunari K.Q. Zhu R.T. Armendariz H. Deubner P. Muangman G.J. Carrougher Histology of the thick scar on the female, red Duroc pig: final similarities to human hypertrophic scar Burns 32 2006 669 677
24. C. He M.A. Hughes G.W. Cherry F. Arnold Effects of chronic wound fluid on the bioactivity of platelet-derived growth factor in serum-free medium and its direct effect on fibroblast growth Wound Repair Regen 7 1999 97 105
25. C.H. Heldin A. Wasteson L. Fryklund B. Westermark Somatomedin B: mitogenic activity derived from contaminant epidermal growth factor Science 213 1981 1122 1123
26. D.C. Hocking J. Sottile T. Reho R. Fassler P.J. McKeown-Longo Inhibition of fibronectin matrix assembly by the heparin-binding domain of vitronectin J Biol Chem 274 1999 27257 27264
27. B. Hollier D.G. Harkin D. Leavesley Z. Upton Responses of keratinocytes to substrate-bound vitronectin: growth factor complexes Exp Cell Res 305 2005 221 232
28. C. Hyde B. Hollier A. Anderson D. Harkin Z. Upton Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration J Invest Dermatol 122 2004 1198 1206
29. Y.C. Jang R. Tsou N.S. Gibran F.F. Isik Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice Surgery 127 2000 696 704
30. W.J. Jeffcoate P. Price K.G. Harding Wound healing and treatments for people with diabetic foot ulcers Diabetes Metab Res Rev 20 Suppl 1 2004 S78 S89
31. R.W. Jyung J.A. Mustoe W.H. Busby D.R. Clemmons Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1 Surgery 115 1994 233 239
32. J.F. Krane D.P. Murphy D.M. Carter J.G. Krueger Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor J Invest Dermatol 96 1991 419 424
33. D.I. Leavesley M.A. Schwartz M. Rosenfeld D.A. Cheresh Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms J Cell Biol 121 1993 163 170
34. S.E. Lynch R.B. Colvin H.N. Antoniades Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds J Clin Invest 84 1989 640 646
35. A. Noble C. Towne L. Chopin D. Leavesley Z. Upton Insulin-like growth factor-II bound to vitronectin enhances MCF-7 breast cancer cell migration Endocrinology 144 2003 2417 2424
36. R.S. Rees M.C. Robson J.M. Smiell B.H. Perry Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study Wound Repair Regen 7 1999 141 147
37. J.G. Rheinwald H. Green Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells Cell 6 1975 331 343
38. M.C. Robson T.A. Mustoe T.K. Hunt The future of recombinant growth factors in wound healing Am J Surg 176 1998 80S 82S
39. M.C. Robson L.G. Phillips W.T. Lawrence J.B. Bishop J.S. Youngerman P.G. Hayward The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores Ann Surg 216 1992 401 406 discussion 406–408
40. M.C. Robson L.G. Phillips A. Thomason L.E. Robson G.F. Pierce Platelet-derived growth factor BB for the treatment of chronic pressure ulcers Lancet 339 1992 23 25
41. M.C. Robson T.J. Phillips V. Falanga D.J. Odenheimer L.C. Parish J.L. Jensen Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers Wound Repair Regen 9 2001 347 352
42. C. Rubin G. Gur Y. Yarden Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation Cell Res 15 2005 66 71
43. R. Rustogi J. Mill J.F. Fraser R.M. Kimble The use of Acticoat in neonatal burns Burns 31 2005 878 882
44. M. Schoppet T. Chavakis N. Al-Fakhri S.M. Kanse K.T. Preissner Molecular interactions and functional interference between vitronectin and transforming growth factor-beta Lab Invest 82 2002 37 46
45. D. Seiffert D.J. Loskutoff Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo J Biol Chem 271 1996 29644 29651
46. H. Smola G. Thiekotter N.E. Fusenig Mutual induction of growth factor gene expression by epidermal–dermal cell interaction J Cell Biol 122 1993 417 429
47. T.P. Sullivan W.H. Eaglstein S.C. Davis P. Mertz The pig as a model for human wound healing Wound Repair Regen 9 2001 66 76
48. T. Sun S. Jackson J.W. Haycock S. MacNeil Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents J Biotechnol 122 2006 372 381
49. G. Topping J. Malda R.A. Dawson Z. Upton Development and characterisation of human skin equivalents and their potential application as a burn wound model Primary Intention 1 2006 14 21
50. N.J. Trengove H. Bielefeldt-Ohmann M.C. Stacey Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers Wound Repair Regen 8 2000 13 25
51. R. Tsuboi C.M. Shi C. Sato G.N. Cox H. Ogawa Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models J Invest Dermatol 104 1995 199 203
52. I.C. Valencia A. Falabella R.S. Kirsner W.H. Eaglstein Chronic venous insufficiency and venous leg ulceration J Am Acad Dermatol 44 2001 401 421
53. J. Wang M. Boerma Q. Fu M. Hauer-Jensen Radiation responses in skin and connective tissues: effect on wound healing and surgical outcome Hernia 10 2006 502 506
54. S. Werner H. Smola Paracrine regulation of keratinocyte proliferation and differentiation Trends Cell Biol 11 2001 143 146
55. E. Wijelath J. Murray-Wijelath W.P. Hammond Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor 2000 International Patent Application WO0055206A1
56. K.Q. Zhu L.H. Engrav N.S. Gibran J.K. Cole H. Matsumura M. Piepkorn The female, red Duroc pig as an animal model of hypertrophic scarring and the potential role of the cones of skin Burns 29 2003 649 664